These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29080)

  • 1. Cerebral transmitter precursors and metabolites in advanced renal disease.
    Sullivan PA; Murnaghan D; Callaghan N; Kantamaneni BD; Curzon G
    J Neurol Neurosurg Psychiatry; 1978 Jul; 41(7):581-8. PubMed ID: 29080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain transmitter precursors and metabolites in diabetic ketoacidosis.
    Curzon G; Kantamaneni BD; Callaghan N; Sullivan PA
    J Neurol Neurosurg Psychiatry; 1982 Jun; 45(6):489-93. PubMed ID: 6181209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease.
    Sullivan PA; Murnaghan D; Callaghan N; Kantamaneni BD; Curzon G
    J Neurol Neurosurg Psychiatry; 1980 Aug; 43(8):739-43. PubMed ID: 6159456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.
    Young SN; Lal S; Sourkes TL; Feldmuller F; Aronoff A; Martin JB
    J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):322-30. PubMed ID: 1141919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.
    Curzon G; Kantamaneni BD; Bartlett JR; Bridges PK
    J Neurochem; 1976 Mar; 26(3):613-5. PubMed ID: 4585
    [No Abstract]   [Full Text] [Related]  

  • 6. Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients.
    Curzon G; Kantamaneni BD; Van Boxel P; Gillman PK; Bartlett JR; Bridges PK
    Acta Psychiatr Scand Suppl; 1980; 280():3-20. PubMed ID: 6157303
    [No Abstract]   [Full Text] [Related]  

  • 7. Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients.
    Bridges PK; Bartlett JR; Sepping P; Kantamaneni BD; Curzon G
    Psychol Med; 1976 Aug; 6(3):399-405. PubMed ID: 996200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and serotonin metabolism in hepatic encephalopathy.
    Knell AJ; Davidson AR; Williams R; Kantamaneni BD; Curzon G
    Br Med J; 1974 Mar; 1(5907):549-51. PubMed ID: 4817189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter precursors and metabolites in CSF of human neonates.
    Anderson GM; Hoder EL; Shaywitz BA; Cohen DJ
    Dev Med Child Neurol; 1985 Apr; 27(2):207-14. PubMed ID: 2581835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid metabolites and precursor amino acids of 5-hydroxytryptamine and dopamine in affective and other psychiatric disorders.
    Korf J; van den Burg W; van den Hoofdakker RH
    Psychiatr Clin (Basel); 1983; 16(1):1-16. PubMed ID: 6189146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and brain tryptophan changes in experimental acute hepatic failure.
    Curzon G; Kantamaneni BD; Winch J; Rojas-Bueno A; Murray-Lyon IM; Williams R
    J Neurochem; 1973 Jul; 21(1):137-45. PubMed ID: 4720891
    [No Abstract]   [Full Text] [Related]  

  • 12. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
    Takahashi S; Abe T
    No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total and free tryptophan concentration in the plasma of depressive patients.
    Coppen A; Eccleston EG; Peet M
    Lancet; 1973 Jul; 2(7820):60-3. PubMed ID: 4123618
    [No Abstract]   [Full Text] [Related]  

  • 14. Ventricular size and CSF transmitter metabolite concentrations in severe endogenous depression.
    Standish-Barry HM; Bouras N; Hale AS; Bridges PK; Bartlett JR
    Br J Psychiatry; 1986 Apr; 148():386-92. PubMed ID: 2425882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of the probenecid test for measurement of monoamine turnover in the CNS.
    Faull KF; Kraemer HC; Barchas JD; Berger PA
    Biol Psychiatry; 1981 Sep; 16(9):879-99. PubMed ID: 6170352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggression and personality: association with amino acids and monoamine metabolites.
    Møller SE; Mortensen EL; Breum L; Alling C; Larsen OG; Bøge-Rasmussen T; Jensen C; Bennicke K
    Psychol Med; 1996 Mar; 26(2):323-31. PubMed ID: 8685288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain monoamine metabolites and tryptophan in ventricular CSF of patients with spasm after aneurysm surgery.
    Vapalahti M; Hyyppä MT; Nieminen V; Rinne UK
    J Neurosurg; 1978 Jan; 48(1):58-63. PubMed ID: 619025
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow.
    Young SN; Lal S; Martin JB; Ford RM; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(6):439-44. PubMed ID: 4781523
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of neurotransmitters in the genesis of uremic encephalopathy.
    Biasioli S; D'Andrea G; Chiaramonte S; Fabris A; Feriani M; Ronco C; Borin D; Brendolan A; La Greca G
    Int J Artif Organs; 1984 Mar; 7(2):101-6. PubMed ID: 6145671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.
    Williams WA; Shoaf SE; Hommer D; Rawlings R; Linnoila M
    J Neurochem; 1999 Apr; 72(4):1641-7. PubMed ID: 10098872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.